Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMAB | NAGE | IMRX | ||
| Company | Y-Mabs Therapeutics Inc | Niagen Bioscience Inc | Immuneering Corp Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.59 | 4.74 | 6.17 | ||
| High | 8.61 | 4.96 | 6.22 | ||
| Low | 8.59 | 4.73 | 5.82 | ||
| Latest | 8.61 | 4.93 | 6.04 | ||
| Change | +0.02 | +0.20 | -0.09 | ||
| % Change | +0.23% | +4.23% | -1.47% | ||
| Volume | 760,600 | 489,300 | 748,000 | ||
| 20-Day Average Volume | 874,510 | 679,010 | 741,980 | ||
| Previous Close | 8.59 | 4.73 | 6.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.56 | 4.61 | 5.52 | ||
| 20-Day Raw Stochastic | 100.00% | 86.52% | 86.86% | ||
| 20-Day Relative Strength | 77.65 | 52.37 | 59.56 | ||
| Weighted Alpha | -45.79 | -34.83 | +117.18 | ||
| Today's Opinion | 88% Buy | 64% Sell | 24% Buy | ||
| Previous Opinion | 88% Buy | 80% Sell | 8% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.23% since 09/08/25 | +1.86% since 04/17/26 | +8.63% since 04/17/26 | ||
| Low | 8.57 on 09/11/25 | 4.71 on 04/23/26 | 5.28 on 04/20/26 | ||
| High | 8.61 on 09/15/25 | 5.05 on 04/22/26 | 6.22 on 04/24/26 | ||
| 1-Month | |||||
| %Chg | +1.06% since 08/15/25 | +8.59% since 03/24/26 | +15.49% since 03/24/26 | ||
| Low | 8.51 on 08/18/25 | 4.16 on 03/30/26 | 4.85 on 03/30/26 | ||
| High | 8.61 on 09/15/25 | 5.05 on 04/22/26 | 6.22 on 04/24/26 | ||
| 3-Month | |||||
| %Chg | +82.80% since 06/13/25 | -17.97% since 01/23/26 | +12.69% since 01/23/26 | ||
| Low | 3.90 on 06/20/25 | 4.16 on 03/30/26 | 4.49 on 02/02/26 | ||
| High | 8.61 on 09/15/25 | 6.29 on 01/28/26 | 6.22 on 04/24/26 | ||
| 6-Month | |||||
| %Chg | +84.37% since 03/14/25 | -34.87% since 10/24/25 | unch since 10/24/25 | ||
| Low | 3.55 on 05/15/25 | 4.16 on 03/30/26 | 4.04 on 01/13/26 | ||
| High | 8.61 on 09/15/25 | 7.95 on 11/05/25 | 8.48 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 391,221 | 394,794 | 390,770 | ||
| Shares Outstanding, K | 45,438 | 80,080 | 64,697 | ||
| Annual Sales | 87,690,000 | 129,420,000 | 0 | ||
| Annual Net Income | -29,670,000 | 17,380,000 | -56,020,000 | ||
| Last Quarter Sales | 19,530,000 | 33,840,000 | 0 | ||
| Last Quarter Net Income | -3,240,000 | 4,130,000 | -11,580,000 | ||
| 60-Month Beta | 0.53 | 2.23 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/08/25 | 0.03 on 03/04/26 | -0.18 on 03/06/26 | ||
| Latest Earnings Date | 11/14/25 | 05/06/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.56 | 0.00 | ||